Singapore Markets closed

LLY Jan 2024 150.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
192.000.00 (0.00%)
At close: 02:24PM EDT
Full screen
Previous close192.00
Open192.00
Bid194.65
Ask197.90
Strike150.00
Expiry date2024-01-19
Day's range192.00 - 192.00
Contract rangeN/A
Volume4
Open interest14
  • Motley Fool

    3 Stocks That Could Benefit From the Ozempic Craze

    Ozempic is a drug that has been soaring in popularity over the past year. Three companies that can benefit from the excitement around this weight-loss treatments are Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY), and WW International (NASDAQ: WW). The biggest benefactor of Ozempic's popularity is likely to be the company that makes the treatment itself: Novo Nordisk.

  • Motley Fool

    3 Dividend Stocks That Have Been Paying Investors Since the 1800s

    Three businesses that have not only been around for more than a century but have also been paying dividends going back to the 1800s are Eli Lilly (NYSE: LLY), ExxonMobil (NYSE: XOM), and the Toronto-Dominion Bank (NYSE: TD). Healthcare giant Eli Lilly has been paying a dividend since 1885.

  • Reuters

    Boehringer's profit up as Jardiance gains offset higher costs

    FRANKFURT (Reuters) -German unlisted drugmaker Boehringer Ingelheim said on Wednesday its operating income rose 1.4% in 2022, as more prescriptions of diabetes drug Jardiance trumped higher energy and development costs. Family-owned Boehringer said in its annual report that full-year operating income came in at 4.77 billion euros ($5.17 billion), up from 4.71 billion a year earlier. The Jardiance group of products, managed in a partnership with Eli Lilly, made 5.8 billion euros in sales, a currency-adjusted surge of 39.1%.